Yeung CHC, Wright AK, Windred DP, et al. Impaired Rest-Activity Rhythm Characteristics Predict Higher Risk of Incident Type 2 Diabetes in UK Biobank Participants. Diabetes care. 2025;48(8):1425-1433. doi:10.2337/dc25-0309
Publications
Scarmeas N, De La Colina AN. The duality of disease: the Alzheimer’s disease dilemma through the lens of nosos and asthenia. Brain : a journal of neurology. 2025. doi:10.1093/brain/awaf239
Hu J, Ye Y, Zhang C, Ruan Y, Natarajan P, Zhao H. Robust pleiotropy-decomposed polygenic scores identify distinct contributions to elevated coronary artery disease polygenic risk. PLoS computational biology. 2025;21(6):e1013191. doi:10.1371/journal.pcbi.1013191
Strausz S, Broberg M, Jones SE, et al. Genetic associations between serotonin receptor 1F () regulatory variation and sleep apnoea in non-obese individuals: insights from GWAS and eQTL analyses. The European respiratory journal. 2025;66(3). doi:10.1183/13993003.01778-2024
Xiong Y, Krebs K, Jermy B, et al. Genome-wide association meta-analysis and rare copy number variant analysis of treatment-resistant depression. Molecular psychiatry. 2025. doi:10.1038/s41380-025-03084-z
Richards SE V, Yang M, Deik AA, Ricq EL. APOE Genotype Impacts Polyunsaturated Neutral Lipid Storage and Ferroptosis Vulnerability in Astrocytes. Neurochemical research. 2025;50(4):211. doi:10.1007/s11064-025-04463-2
Yang Q, Safina KR, Nguyen KDQ, Tuong ZK, Borcherding N. scRepertoire 2: Enhanced and efficient toolkit for single-cell immune profiling. PLoS computational biology. 2025;21(6):e1012760. doi:10.1371/journal.pcbi.1012760
Jassim A, Nimmervoll B V, Terranova S, et al. Gene context drift identifies drug targets to mitigate cancer treatment resistance. Cancer cell. 2025;43(9):1608-1621.e9. doi:10.1016/j.ccell.2025.06.005
Gupta S, Mistry K, Alikhan FM, et al. Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor-associated acute interstitial nephritis. Kidney international. 2025;108(3):491-496. doi:10.1016/j.kint.2025.05.029
Spitz J, Patel J, Agarwala A, et al. A Critical Appraisal of Lipid Management in the Post-Statin Era: Comparison on Guidelines, Therapeutic Targets, and Screening in a Case-Based Framework of Lipid Management. JACC. Advances. 2025;4(6 Pt 2):101823. doi:10.1016/j.jacadv.2025.101823